Pharma Mar | PHM - Assets

Stock Price
96.30
Daily Change
-1.30 -1.33%
Monthly
-1.23%
Yearly
22.68%
Q2 Forecast
93.78

Pharma Mar reported EUR385.26M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Almirall EUR 2.34B 29.21M Dec/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Pharma Mar EUR 385.26M 9.82M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026